ArticleCardiovascular diabetology. Endocrinology reports2026
From dual to quintuple agonism for next-generation pharmacology to treat obesity and type 2 diabetes: synergistic incretin and nuclear receptor signaling.
Gaetano SantulliPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.